MultiPlan Investor Investigation
Girard Sharp is investigating potential claims on behalf of MultiPlan stockholders arising out of the merger of MultiPlan with Churchill Capital Corporation, a special purpose acquisition company (“SPAC”).
If you invested in Churchill and/or MultiPlan, you may have a claim for relief.
Protect your rights by speaking with a Girard Sharp attorney—dial (866) 981-4800 or submit your information below.
Speak to a Lawyer
More Information on MultiPlan Investigation
MultiPlan Corporation is a data analytics provider for healthcare companies and consumers. On October 7, 2020, the merger between MultiPlan and Churchill Capital closed. A month later, a market research report on MultiPlan published by Muddy Waters LLC revealed that MultiPlan had lost the business of UHC, a customer that had been providing 35% of its revenues. As a result, the company’s financial position was severely weakened, the report found. The company’s share price then fell by nearly 40%.
Our Commitment to Excellence
Girard Sharp has earned national Tier 1 rankings for Mass Tort and Class Action Litigation and has been named to the U.S. News – Best Lawyers “Best Law Firms” list each year since 2013. Read about some of our results.
We have recovered over a billion dollars for our clients against some of the nation’s largest corporations, such as Raymond James, Peregrine Financial Group, and OppenheimerFunds, in cases arising from securities fraud, false advertising and other unfair business practices.
For a free consultation about your potential claims, contact one of our investment fraud attorneys at (866) 981-4800 or by filling out the form above.